Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.71
-0.04 (-0.59%)
At close: Dec 5, 2025, 4:00 PM EST
6.70
-0.01 (-0.15%)
After-hours: Dec 5, 2025, 6:03 PM EST
Nuvectis Pharma Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Nuvectis Pharma stock have an average target of 15.33, with a low estimate of 10 and a high estimate of 19. The average target predicts an increase of 128.46% from the current stock price of 6.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 4, 2025.
Analyst Ratings
The average analyst rating for Nuvectis Pharma stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +49.03% | Aug 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 → $15 | Strong Buy | Reiterates | $11 → $15 | +123.55% | Apr 30, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +153.35% | Apr 2, 2025 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +183.16% | Mar 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $11 | Strong Buy | Maintains | $21 → $11 | +63.93% | Feb 25, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.33
from -1.11
EPS Next Year
-1.06
from -1.33
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.25 | -0.91 | |
| Avg | -1.33 | -1.06 | |
| Low | -1.33 | -1.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.